United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$141Mraised across 4 rounds since 1999, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
New Enterprise Associates
Kleiner Perkins Caufield & Byers
InterWest PartnersReported by bizjournals.comSEC filing: $18M sold, first sale Jul 2013
No investor was named in the report.
Reported by fis.dowjones.comSEC filing: $49M sold, first sale Aug 2011
From the SEC filings it signed: 3 on the team.
On the board, as filediEvan NortonGreg GarfieldJoseph LacobNael KassarRenee RyanRishi GuptaVince Burgess
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
New Enterprise AssociatesKleiner Perkins Caufield & Byers
OrbiMedInterWest PartnersMissing a round, or an investor who was in one? Tell us.
These 2 firms list NeuroPace as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
NeuroPace's investors include New Enterprise Associates, Kleiner Perkins Caufield & Byers, OrbiMed, InterWest Partners and Johnson & Johnson Development Corporation (JJDC), and 3 more on record.
NeuroPace has raised $141M across 4 rounds since 1999. One round did not disclose an amount, so the total is a floor.
NeuroPace's most recent round was an Undisclosed round of $74M in Oct 2017.
Its most recent round, $74M in Oct 2017, is also its largest on record.
NeuroPace's first round on record, in Dec 1999, was backed by Accelerated Growth Partners.
NeuroPace's latest named round is an Undisclosed round, in Oct 2017.
NeuroPace is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
